InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,727.16
(
-0.10%
)
US TECH 100
19,444.80
(
0.15%
)
Dow Jones
41,956.87
(
-0.60%
)
Brent Oil
73.10
(
-1.96%
)
Bitcoin
63,636.88
(
-0.98%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

chickpea598

Send PM Follow Ignore
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

chickpea598

Re: None

Thursday, 02/23/2017 2:33:46 PM

Thursday, February 23, 2017 2:33:46 PM

Post# of 48316
Patience will prevail with Oncosec. Looking over the data presented today shows that some patients are taking longer to have a complete response but are indeed having a response. From 6 to 12 months we have a response rate of 43% to 48%. That is fantastic, but the market is still looking for absolute proof of concept. All 22 patients were selected using the biomarker assay so they are all "predicted non-responders". We will need to see any data from newly enrolled patients that have absolutely failed monotherapy already. Look forward to this at the next Asco conference in June.
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Start posting your company's news
Only $200 per official company press release!